OI Ljubljana
Sl

Improving breast cancer screening through dynamic big data analytics of Quantitative Imaging Biomarkers

BASIC DATA OF THE RESEARCH PROJECT

  • ARRS code: N1-0197
  • TITLE: Improving breast cancer screening through dynamic big data analytics of Quantitative Imaging Biomarkers
  • PROJECT LEADER: Assoc. Prof. Robert Jeraj
  • DURATION: 1.1.2021 - 31.12.2024     
  • APPLICANT RESEARCH ORGANISATION: University of Ljubljana, Faculty of Mathematics and Physics
  • PARTICIPATING RESEARCH ORGANISATIONS: INSTITUTE OF ONCOLOGY LJUBLJANA
  • FINANCING: Slovenian Research Agency

BRIEF DESCRIPTION OF THE PROJECT

Breast cancer still represents a major health problem. Mortality rates, both in Flanders and Slovenia, are similar and above the European average. While both regions have successful breast screening programs, the overall detection rates are still too low. Two main factors contribute to missed cancers: “dense breasts” which lead to a five-fold occurrence of breast cancer and “tissue masking”, resulting from complex glandular tissue structure. These challenges will be addressed by combining approaches pioneered by the two lead investigators from Flanders and Slovenia. An improved screening methodology will be developed by (1) integrating dynamic changes from one screening time point to another (longitudinal assessment) and (2) harnessing the power of big data analytics to extract cancer predictive features (spatial assessment). A retrospective study will identify hand crafted (radiomics) and machine-learning based (Convolutional Neural Networks) features on a data base of 9000 women in Flanders and Slovenia. These biomarkers will then be validated prospectively on at least 100 patients per year at each site. The international quantitative imaging framework will be leveraged (Networks of Imaging eXcellence (NIX)-Alliance) to provide the infrastructural backbone for imaging biomarker extraction and testing/fine-tuning. Our results will improve current breast screening schemes with an objective, risk-based stratification procedure based on a personalized risk score.

 

 

© 2019 - Institute of Oncology Ljubljana
Accessibility(CTRL+F2)
color contrast
text size
highlighting content
zoom in